Should You Buy IHS Holding Ltd (IHS) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
7.920
1 Day change
1.28%
52 Week Range
8.210
Analysis Updated At
2026/01/26
IHS Holding Ltd is not a strong buy for a beginner, long-term investor at this moment. While the stock has shown some positive technical indicators and a recent price target increase from Citi, the financial performance is weak, with significant declines in net income and EPS. Additionally, the lack of strong trading signals, neutral hedge fund and insider sentiment, and mixed analyst ratings suggest a cautious approach. The investor should wait for clearer positive catalysts or improved financial performance before considering an investment.
Technical Analysis
The stock's technical indicators are mixed. The MACD is slightly positive, but contracting, and the RSI is neutral at 52.839. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating a potential upward trend. Key support and resistance levels are Pivot: 7.724, R1: 8.068, S1: 7.381, R2: 8.281, S2: 7.168. However, the stock's recent price action shows a -2.78% regular market change, indicating short-term weakness.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
The low put-call ratios suggest a bullish sentiment in the options market, but the overall trading volume is relatively low, limiting the reliability of this data.
Moving Average Consensus
Sell
1
Buy
9
Positive Catalysts
2026/01/26 01:16:06
Citi recently raised its price target to $9 from $8.75 and maintained a Buy rating. The company's revenue increased by 8.28% YoY in Q3 2025.
Neutral/Negative Catalysts
2026/01/26 01:16:06
JPMorgan downgraded the stock to Underweight with a price target of $6, citing modest growth in key markets like Nigeria and Africa. Financial performance is weak, with net income and EPS declining significantly (-173.97% and -173.77% YoY, respectively). No recent news or significant trading trends from hedge funds or insiders.
Financial Performance
In Q3 2025, revenue grew by 8.28% YoY to $455.1M, but net income dropped by 173.97% YoY to $151M, and EPS fell by 173.77% YoY to 0.45. Gross margin also declined to 47.37%, down 9.53% YoY, indicating worsening profitability.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Analyst ratings are mixed. Citi raised its price target to $9 and maintained a Buy rating, while JPMorgan downgraded the stock to Underweight with a $6 price target. Goldman Sachs raised its price target to $7 but kept a Neutral rating.
Wall Street analysts forecast IHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IHS is 11 USD with a low forecast of 6 USD and a high forecast of 17 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast IHS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IHS is 11 USD with a low forecast of 6 USD and a high forecast of 17 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
1 Sell
Moderate Buy
Current: 7.820
Low
6
Averages
11
High
17
Current: 7.820
Low
6
Averages
11
High
17
Citi
Michael Rollins
Buy
maintain
$9
AI Analysis
2025-11-24
Reason
Citi
Michael Rollins
Price Target
$9
AI Analysis
2025-11-24
maintain
Buy
Reason
Citi analyst Michael Rollins raised the firm's price target on IHS Holding to $9 from $8.75 and keeps a Buy rating on the shares.
JPMorgan
Overweight -> Underweight
downgrade
$8 -> $6
2025-11-14
Reason
JPMorgan
Price Target
$8 -> $6
2025-11-14
downgrade
Overweight -> Underweight
Reason
JPMorgan double downgraded IHS Holding to Underweight from Overweight with a price target of $6, down from $8. The shares are up 120% year-to-date as the company has addressed the issues that negatively impacted the stock in 2024 and continued to execute, the analyst tells investors in a research note. The firm now sees more upside to the other tower stocks due to its "modest" growth outlook for IHS's Nigeria and Africa businesses. The company's long-term outlook is uncertain, contends JPMorgan.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IHS
